Shelia M. Violette sold $13k of QTTB
Chief Scientific Officer at Q32 Bio Inc.. 2,815 shares at an average of $4.51, traded Feb 25, 2026, filed Feb 27, 2026.
Score components
- +15RoleOfficer
- 0Trade size$13k at market
- 0Share of holdings soldSold 4.8% of holdings
- +15Cluster3 insiders selling within 14 days
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
This signal so far: 1m +59.0%, 3m +142.3%, 6m +229.6%.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001193125-26-083584, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Feb 25, 2026 | SOpen-market sale Common Stock | -2,815 | $4.51 | $13k | 55,569 | Feb 27, 2026 |
Related signals
Other insiders at Q32 Bio Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 45Moderate | Q32 Bio Inc. | Lee Kalowski CFO and President | $66k 3,972 shares | -3% | |
| 51Moderate | Q32 Bio Inc. | Jodie Pope Morrison CEO | $163k 9,845 shares | -3% | |
| 36Weak | Q32 Bio Inc. | Shelia M. Violette Chief Scientific Officer | $46k 2,798 shares | -2% | |
| 57Moderate | Q32 Bio Inc. | Orbimed Advisors LLC director, owner | $15M 1,875,000 shares | +83% | |
| 62Notable | Q32 Bio Inc. | Diyong Xu director, owner | $15M 1,875,000 shares | +83% | |
| 42Moderate | Q32 Bio Inc. | Lee Kalowski CFO and President | $18k 3,995 shares | -10% | |
| 46Moderate | Q32 Bio Inc. | Jodie Pope Morrison CEO | $45k 9,896 shares | -10% | |
| 40Moderate | Q32 Bio Inc. | Lee Kalowski CFO and President | $31k 9,072 shares | -19% | |
| 47Moderate | Q32 Bio Inc. | Jodie Pope Morrison CEO | $78k 22,506 shares | -19% | |
| 37Weak | Q32 Bio Inc. | Lee Kalowski CFO and President | $7,636 4,240 shares | -8% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.